
Achieve Life Sciences Inc
ACHVNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$5.35
Day High
$5.49
Day Low
$5.24
Prev. Close
$5.30
VolumeShares traded today.
996.55K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$537.93M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-4.71
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$6.15
52W LowLowest price over the past 52 weeks.
$2.00
50D MAAverage closing price over the last 50 trading days.
$4.20
200D MAAverage closing price over the last 200 trading days.
$4.15
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+13.9%1M
+26.3%6M
+14.2%YTD
+5.4%1Y
+46.4%About
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
achievelifesciences.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade ACHV
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.